Investment Rating - The investment rating for Meiji Holdings is Neutral, with a 12-month target price revised to ¥3,400 from ¥3,500, reflecting a slight decrease in operating profit estimates [1][18][22]. Core Insights - The report indicates that operating profits for FY3/25 are expected to miss guidance, primarily due to anticipated shortfalls in sales across domestic milk, the dairy overseas business, and the vaccines/animal health business [1][17]. - The company has a significant market share in Japan for dairy products, chocolate, and protein products, but its growth prospects are considered to be adequately reflected in the current share price [22]. - The report highlights the importance of monitoring input costs, price hikes, and sales recovery in the food segment, as well as growth in the pharmaceuticals segment, particularly in vaccines and overseas business expansion [19][22]. Financial Estimates - FY3/26 operating profit estimates have been adjusted by -0.1% for the overall company, with specific adjustments of +¥0.7 billion for the food segment and +¥0.2 billion for the pharmaceuticals segment, while adjustments account for a decrease of -¥1.0 billion [1][17]. - Sales estimates for FY3/26 are projected at ¥1,192.2 billion, reflecting a year-on-year growth of 3.3% [3][20]. - The net profit for FY3/26 is estimated at ¥53.9 billion, with an EPS of ¥202.1 [3][20]. Segment Performance - The food segment's operating profit is expected to be ¥70.7 billion for FY3/26, while the pharmaceuticals segment is projected at ¥25.7 billion [20]. - Key areas of focus for the food segment include dairy, chocolate, and nutrition, with specific sales estimates for dairy at ¥273.5 billion and chocolate at ¥177.2 billion for FY3/26 [20]. - The pharmaceuticals segment is anticipated to see growth driven by vaccines and the expansion of the overseas CMO/CDMO business, despite challenges from drug price revisions [19][22].

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

26 May 2025 | 7:05AM CST China Solar: Tracking profitability inflection May profitability to drop below pre-rush installation levels, price stabilization efforts as key to watch Our China Solar Profitability Tracker follows monthly supply/demand and inventory dynamics by sub-sector, and the spot prices/input costs implied cash GP & EBITDA margin trends for companies under our coverage. Key highlights in May MTD: Goldman Sachs does and seeks to do business with companies covered in its research reports. As a ...

Core Viewpoint - Astronics Corporation's stock price has increased by 100% year-to-date, driven by strong business performance and the resolution of legacy patent disputes [1][2] Company Performance - The company supplies parts and components to the aerospace industry, experiencing thriving business conditions with a shift towards profitability and sustained double-digit revenue growth [2] - Q1 2025 highlights include a 700 basis points top-line outperformance, with gross and operating margins expanding by over 500 basis points, leading to adjusted earnings increasing by over 400% [3] Financial Guidance - Astronics reaffirmed its 2025 outlook, projecting approximately 6% revenue growth at the midpoint range, with expectations for improved guidance in subsequent quarters [4] Balance Sheet Strength - The balance sheet shows increased cash and assets, reduced debt, and improved shareholder equity by over 4% in Q1, indicating robust operational capacity [5][6] Market Activity - Institutional investors own about 57% of the stock and are actively buying, with buying activity outpacing selling by more than four times [6][7] - Short interest was nearly 10% at the end of April, which could amplify the positive market impact from institutional buying [7] Stock Price Forecast - The 12-month stock price forecast is set at $21.00, indicating a potential downside of 33.80% from the current price [8][9] Upcoming Catalysts - The next significant event is the Q2 earnings release scheduled for early August, with analysts forecasting about 5% sequential growth and margin strength [10]

Press release Montrouge, 28 May 2025 2025 CAPITAL INCREASERESERVED FOR EMPLOYEES OF THE CRÉDIT AGRICOLE GROUP Today, Crédit Agricole S.A. is pleased to announce the launch of its annual capital increase reserved for employees of the Crédit Agricole Group around the world. Crédit Agricole S.A. will give the 190,000 eligible Crédit Agricole Group employees and retired former employeesi the option to subscribe to new Crédit Agricole S.A. shares. For the 2025 reserved capital increase, the share’s subscription ...

The Management Board of AB Kauno Energija (hereinafter – the Company) (code – 235014830) assessed the results of Company’s business activity of the 1 quarter of the year 2025 and financial state as at March 31, 2025 and approved on May 26, 2025 AB Kauno Energija consolidated and Company’s non-audited results of the 1 quarter of the year 2025. The result of Company’s business activities of the 1 quarter of the year 2025 according to the International Financial Reporting Standards is profit (before taxes) in ...

Core Insights - Bilibili (BILI) reported strong results for 1Q25, with revenue largely in line with expectations and profit exceeding consensus estimates [1] - All key business segments of Bilibili outperformed industry growth, indicating a positive trajectory towards profitability [1] Financial Performance - Bilibili's revenue for 1Q25 was consistent with market expectations, while profits were ahead of consensus [1] - The performance across all business segments suggests robust operational metrics supporting the company's growth strategy [1] Market Position - Bilibili's ability to deliver results above industry growth rates reinforces its competitive position in the market [1] - The company's focus on enhancing portfolio performance and uncovering alpha opportunities is supported by a strong track record in investment research [1]

Core Insights - The article emphasizes the importance of combining financial data with qualitative analysis to evaluate companies and sectors, particularly in technology, infrastructure, and internet services [1]. Company Focus - The analysis is directed towards companies with strong fundamentals and growth potential, indicating a preference for long-term investment strategies [1]. Sector Interest - The sectors of interest include technology, healthcare, and finance, highlighting a diverse investment approach [1].

Urban Outfitters, Inc. (URBN) reported impressive results for first-quarter fiscal 2026, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. Also, both metrics improved from the prior-year quarter’s reported figure. As a result, shares of this Philadelphia, PA-based player rose 17.5% in the after-market trading session yesterday.The company reported a highly successful quarter, showcasing strong performance across all its brands and business segments. The Retail segment’s comparable sal ...

Canada Goose TodayGOOSCanada Goose$11.17 +2.25 (+25.22%) 52-Week Range$6.73▼$14.75P/E Ratio21.68Price Target$9.50Add to WatchlistCanada Goose's NYSE: GOOS stock price surged by 30% following its FQ4 report, highlighting both its brand loyalty and high short interest. The short interest is a primary factor in the stock's sudden price spike. Although down from the peaks set in 2022, it was still remarkably high at the start of May, running above 20%. The short interest likely fell following the Q4 release.Ge ...